Unique ID issued by UMIN | UMIN000032879 |
---|---|
Receipt number | R000037465 |
Scientific Title | Effect of the ultra-brief cognitive and behavior therapy for patients with type2 diabetes on self-management. |
Date of disclosure of the study information | 2018/06/17 |
Last modified on | 2021/12/13 10:08:43 |
Effect of the ultra-brief cognitive and behavior therapy for patients with type2 diabetes on self-management.
Effect of the ultra-brief cognitive and behavior therapy for patients with type2 diabetes on self-management.
Effect of the ultra-brief cognitive and behavior therapy for patients with type2 diabetes on self-management.
Effect of the ultra-brief cognitive and behavior therapy for patients with type2 diabetes on self-management.
Japan |
Type2 diabetes mellitus
Endocrinology and Metabolism |
Others
NO
This study aims to investigate the effect of ultra-brief cognitive and behavior therapy on Glucose fluctuations and self-management in Japanese out-patients with type 2 diabetes.
Efficacy
Glucose fluctuations data (FreeStyle Libre Pro)
Self-care behavior in daily life (Ecological momentary assessment)
Acceptance and Action Diabetes Questionnaire (AADQ)
Mindfulness Attention Awareness Scale (MAAS)
Values Clarification Questionnaire (VCQ)
Patient Health Questionnaire-9 (PHQ-9)
Body mass index (BMI)
HbA1c
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Behavior,custom |
Ultra-brief cognitive and behavior therapy: 1 session (90min to 120min)
20 | years-old | <= |
79 | years-old | >= |
Male and Female
Japanese out-patients are included if they were between 20 and 79 years-of-age and have been receiving medical care under diagnosis of type 2 diabetes mellitus according to the classifications by the Japan Diabetes Society and World Health Organization.
1) cannot understand Japanese well.
2) type1 diabetes and the secondary forms of diabetes.
3) affected with severe diabetes complication; diabetic retinopathy with impaired vision, impaired renal function (eGFR <30 and macroproteinuria), painful neuropathy.
4) affected with severe cardiovascular diseases and decline in ability of daily life.
5) affected with severe mental illness.
6) Cognitive dysfunction; Altzheimer type dementia, vascular dementia, and so on.
10
1st name | Hiroaki |
Middle name | |
Last name | Kumano |
Waseda University
Faculty of Human Science
359-1192
2-579-15 Mikajima, Tokorozawa, Saitama
+81-4-2949-8113
hikumano@waseda.jp
1st name | Junichi |
Middle name | |
Last name | Saito |
Waseda University
Graduate School of Human Science
359-1192
2-579-15 Mikajima, Tokorozawa, Saitama
+81-4-2949-8113
tekuteke@toki.waseda.jp
Waseda University
Grant-in-Aid for JSPS Research Fellow
Japanese Governmental office
Waseda University
2-579-15 Mikajima, Tokorozawa, Saitama, 359-1192, Japan
+81-3-5272-1639
rinri@list.waseda.jp
YES
2017-298
Waseda University
2018 | Year | 06 | Month | 17 | Day |
Partially published
10
Completed
2018 | Year | 03 | Month | 13 | Day |
2018 | Year | 06 | Month | 17 | Day |
2018 | Year | 06 | Month | 17 | Day |
2021 | Year | 03 | Month | 31 | Day |
2018 | Year | 06 | Month | 05 | Day |
2021 | Year | 12 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037465